PMID- 27309941 OWN - NLM STAT- MEDLINE DCOM- 20170531 LR - 20211204 IS - 1945-7170 (Electronic) IS - 0013-7227 (Print) IS - 0013-7227 (Linking) VI - 157 IP - 8 DP - 2016 Aug TI - Manganese-Stimulated Kisspeptin Is Mediated by the IGF-1/Akt/Mammalian Target of Rapamycin Pathway in the Prepubertal Female Rat. PG - 3233-41 LID - 10.1210/en.2016-1090 [doi] AB - Low-dose administration of manganese chloride (MnCl2) causes release of hypothalamic LH-releasing hormone (LHRH) and advances puberty in rat. Recently, this element was shown to up-regulate mammalian target of rapamycin (mTOR), kisspeptin gene (KiSS-1), and LHRH gene expressions in the brain preoptic area (POA)/anteroventral periventricular (AVPV) nucleus. Because these genes are critical for puberty, this study was conducted to identify the upstream mechanism by which Mn activates the mTOR/KiSS-1 pathway. On day 12, immature female rats began receiving a daily supplemental dose of 10 mg/kg of MnCl2 or saline by gavage, and POA/AVPV tissues were collected on day 29 for specific protein assessments. Another experiment assessed in vitro IGF-1 release in response to Mn and assessed signal transduction pathways in the POA/AVPV region after Mn delivery into the third ventricle. Chronic Mn exposure increased (P < .05) basal expressions of mTOR and kisspeptin proteins. Mn increased protein kinase B (Akt) and Ras homolog enriched in brain, both capable of activating mTOR. Central Mn delivery increased expressions of phosphorylated IGF-1 receptor (IGF-1R) (P < .05) and Akt (P < .01) in the POA/AVPV region. The previous central delivery of JB1, an IGF-1R antagonist, blocked Mn-induced expressions of both phosphorylated IGF-1R and Akt. Downstream to Akt, centrally administered Mn increased tuberous sclerosis complex 2 (P < .05), Ras homolog enriched in brain (P < .01), mTOR (P < .05), and kisspeptin (P < .05). Finally, we observed that the early puberty induced by Mn was blocked by the administration of an mTOR inhibitor. These results suggest that Mn acts, at least in part, through the IGF-1/Akt/mTOR pathway to influence prepubertal kisspeptin and LHRH. FAU - Srivastava, Vinod K AU - Srivastava VK AD - Department of Veterinary Integrative Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, Texas 77843-4458. FAU - Hiney, Jill K AU - Hiney JK AD - Department of Veterinary Integrative Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, Texas 77843-4458. FAU - Dees, William L AU - Dees WL AD - Department of Veterinary Integrative Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, Texas 77843-4458. LA - eng GR - R01 ES013143/ES/NIEHS NIH HHS/United States PT - Journal Article DEP - 20160616 PL - United States TA - Endocrinology JT - Endocrinology JID - 0375040 RN - 0 (Kisspeptins) RN - 42Z2K6ZL8P (Manganese) RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - EC 2.7.11.1 (Oncogene Protein v-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Animals MH - Animals, Newborn MH - Female MH - Insulin-Like Growth Factor I/*metabolism MH - Kisspeptins/*metabolism MH - Manganese/*pharmacology MH - Oncogene Protein v-akt/*metabolism MH - Pregnancy MH - Puberty, Precocious/chemically induced/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - *Sexual Maturation/drug effects/physiology MH - Signal Transduction/drug effects MH - TOR Serine-Threonine Kinases/*metabolism PMC - PMC4967113 EDAT- 2016/06/17 06:00 MHDA- 2017/06/01 06:00 PMCR- 2017/08/01 CRDT- 2016/06/17 06:00 PHST- 2016/06/17 06:00 [entrez] PHST- 2016/06/17 06:00 [pubmed] PHST- 2017/06/01 06:00 [medline] PHST- 2017/08/01 00:00 [pmc-release] AID - EN-16-1090 [pii] AID - 10.1210/en.2016-1090 [doi] PST - ppublish SO - Endocrinology. 2016 Aug;157(8):3233-41. doi: 10.1210/en.2016-1090. Epub 2016 Jun 16.